HIV/AIDS
New HIV/AIDS study findings have been reported by scientists from University of Pittsburgh, U.S.
Published in AIDS Weekly, February 19th, 2007
Study 1: A new study, "Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors," is now available. According to a study from the United States, "The K70E mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) has become more prevalent in clinical samples, particularly in isolates derived from patients for whom triple-nucleoside regimens that include tenofovir (TNV), abacavir, and lamivudine (3TC) failed. To elucidate the molecular mechanism by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-02-19)
More Articles from AIDS Weekly
- HIV/AIDS Research
New compound shows promise in halting HIV spread - HIV/AIDS Therapy
Clinical pharmacists can positively contribute to clinical outcomes for HIV-infected patients - HIV/AIDS
Researchers at University of Pittsburgh, Department of Medicine target HIV/AIDS - HIV/AIDS Co-Infection
Researchers from University of Duisburg-Essen, Department of Neurology report details of new studies and findings in the area of HIV/AIDS co-infection - HIV/AIDS Co-Infection Epidemiology
Reports from London School of Hygiene and Tropical Medicine highlight recent research in HIV/AIDS co-infection epidemiology - HIV/AIDS Co-Infection Therapy
Scientists at University Hospital target HIV/AIDS co-infection therapy - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
